CHARACTERISTICS OF BACTERIAL COINFECTION IN COVID-19 PATIENTS AT HOI SUC COVID-19 HOSPITAL
Main Article Content
Abstract
Object: Describe the characteristics of co-infection and the cumulative antimicrobial susceptibility data in COVID-19 patients at the Hoi Suc COVID-19 hospital. Study subjects: Microbiology data at the Hoi Suc COVID-19 hospital from 01/09/2021 to 31/01/2022. Method: A descriptive cross-sectional study. Results: The proportion of COVID-19 patients with bacterial co-infection was 58.8% (705/1200). The first common types co-infections recorded was respiratory infections accounted for 74.5% (525/705). A total of 843 pathogenic bacteria strains were isolated, of which mainly Gram-negative bacilli with Acinetobacter baumannii accounted for the highest rate of 35.2% (303/843). The cumulative antimicrobial susceptibility data of Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa showed a susceptibility rate under 20% to most antibiotics. Conclusion: More than 50% of severe and critical COVID-19 had bacterial co-infection. The most common infections was respiratory tract infection. The bacteria were less susceptible to commonly used antibiotics.
Article Details
Keywords
Bacterial Coinfections, COVID-19, antimicrobial susceptible
References
2. Westblade LF, Simon MS, Satlin MJ. Bacterial Coinfections in Coronavirus Disease 2019. Trends Microbiol. 2021 Oct;29(10):930–41.
3. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England). 2020 Feb;395(10223):507–13.
4. Garcia-Vidal C, Moreno-García E, Hernández-Meneses M, Puerta-Alcalde P, Chumbita M, Garcia-Pouton N, et al. Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2022 Jan;74(1):127–32.
5. Shafran N, Shafran I, Ben-Zvi H, Sofer S, Sheena L, Krause I, et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep. 2021 Jun;11(1):12703.
6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020 Mar;395(10229):1054–62.
7. Elabbadi A, Turpin M, Gerotziafas GT, Teulier M, Voiriot G, Fartoukh M. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia. Vol. 49, Infection. Germany; 2021. p. 559–62.